Physiological, pharmacological and pathological actions of glucocorticoids on the digestive system
Scott, J.
Clinics in Gastroenterology 10(3): 627-652
1981
ISSN/ISBN: 0300-5089 PMID: 7032759 Document Number: 182236
Document emailed within 1 workday
Related Documents
Matsuda, H.; Imai, S. 1985: Physiological and pharmacological actions of prostaglandins and related substances on the circulatory system Nihon Rinsho. Japanese Journal of Clinical Medicine 43(3): 493-496Kasai, Y.; Abe, K.; Yoshinaga, K. 1985: Physiological and pharmacological actions of prostaglandins and related substances on the endocrine system Nihon Rinsho. Japanese Journal of Clinical Medicine 43(3): 507-513
Filaretova, L.P.; Bagaeva, T.R.; Morozova, O.I.; Podvigina, T.T. 2010: Transformation of physiological gastroprotective effects of glucocorticoids into pathological ulcerogenic consequences Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 96(8): 806-816
Padrini, R.; Piovan, D.; Bova, S.; Moretto, R.; Cargnelli, G.; Ferrari, M. 1987: Physiological, pharmacological and pathological factors affecting the pharmacokinetics of calcium entry blockers Giornale Italiano di Cardiologia 17(9): 786-790
Hirano, T.; Manabe, T.; Printz, H.; Saluja, A.; Steer, M. 1992: Secretion of lysosomal and digestive enzymes into pancreatic juice under physiological and pathological conditions in rabbits Nihon Geka Hokan. Archiv für Japanische Chirurgie 61(2): 103-124
Kubota, K.; Miura, Y. 1985: Physiological and pharmacological actions of prostaglandins and related substances: blood cell differentiation and prostaglandins Nihon Rinsho. Japanese Journal of Clinical Medicine 43(3): 529-536
Andersen, M.; Jensen, C.H.; Støving, R.K.; Larsen, J.B.; Schrøder, H.D.; Teisner, B.; Hagen, C. 2001: Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels Journal of Clinical Endocrinology and Metabolism 86(11): 5465-5470
Jiang, X.R.; Wu, Q.X.; Shi, H.L.; Chen, W.P.; Chang, S.Q.; Zhao, S.Y.; Tian, X.Y.; Zhou, L.F.; Guo, S.M.; Li, Y.J. 1982: Pharmacological actions of dehydrocorydaline on cardiovascular system Yao Xue Xue Bao 17(1): 61-65
Martin, B.R.; Tripathi, H.L.; Aceto, M.D.; May, E.L. 1983: Relationship of the biodisposition of the stereoisomers of nicotine in the central nervous system to their pharmacological actions Journal of Pharmacology and Experimental Therapeutics 226(1): 157-163
Roberts, M.L.; Mashford, M.L. 1972: Possible physiological and pathological roles of the kallikrein-kinin system Medical Journal of Australia 2(16): 887-891
Alekseeva, M.L.; Adamian, L.V.; Slurchak, S.V.; Strizhakov, A.N.; Novikov, E.A. 1980: Characteristics of the endometrial estrogen-receptor system in physiological and various pathological states of the body Problemy Endokrinologii 26(4): 26-28
Kubo, S.; Uesaka, I.; Matsubara, I.; Ishihara, T.; Kasé, Y. 1977: Pharmacological studies of o-chloro-alpha-[(tert.-butylamino)methyl]benzylalcohol hydrochloride (C-78), a new bronchodilator. II. Actions on the cardio-vascular system and smooth muscle organs Arzneimittel-Forschung 27(7): 1433-1439
Altura, B.M.; Altura, B.T. 1974: Peripheral vascular actions of glucocorticoids and their relationship to protection in circulatory shock Journal of Pharmacology and Experimental Therapeutics 190(2): 300-315
Spector, R.G. 1981: Pharmacological properties of the glucocorticoids International Dental Journal 31(2): 152-155
Randrup, A.; Mogilnicka, E. 1976: Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems Polish Journal of Pharmacology and Pharmacy 28(6): 551-556
Haulică, I.; Bild, W.; Boişteanu, D. 2006: Biosynthesis and physio-pharmacological actions of angiotensin peptides: 2. Physio-pharmacological properties Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 110(2): 384-390
Hojo, M.; Nagasaka, Y.; Katayama, O.; Serizawa, I. 1981: Pharmacological study of Mequitazine (LM-209). (V). Pharmacological actions of a main metabolite of LM-209, mequitazine sulfoxide (LM-209 SO) Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 78(5): 431-438
Hidalgo, J.; Giralt, M.; Garvey, J.S.; Armario, A. 1988: Physiological role of glucocorticoids on rat serum and liver metallothionein in basal and stress conditions American Journal of Physiology 254(1 Pt 1): E71-E78
Mantovani, P.; Santicioli, P.; Di Donato, M. 1981: Further experiments on the pharmacological actions of ergometrine Bollettino della Societa Italiana di Biologia Sperimentale 57(12): 1346-1351
Yuan, W.X.; Gui, L.H.; Zhou, J.Y.; Li, Q.Y.; Yu, Q.H. 1983: Some pharmacological actions of ginseng saponins Zhongguo Yao Li Xue Bao 4(2): 124-127